Literature DB >> 8583267

Interpretation of the tuberculin skin test.

D N Rose1, C B Schechter, J J Adler.   

Abstract

OBJECTIVE: To reinterpret epidemiologic information about the tuberculin test (purified protein derivative) in terms of modern approaches to test characteristics; to clarify why different cutpoints of induration should be used to define a positive test in different populations; and to calculate test characteristics of the intermediate-strength tuberculin skin test, the probability of Mycobacterium tuberculosis infection at various induration sizes, the area under the receiver operating characteristic (ROC) curve, and optimal cutpoints for positivity.
METHODS: Standard epidemiologic assumptions were used to distinguish M. tuberculosis-infected from -uninfected persons; also used were data from the U.S. Navy recruit and World Health Organization tuberculosis surveys; and Bayesian analysis.
RESULTS: In the general U.S. population, the test's sensitivity is 0.59 to 1.0, the specificity is 0.95 to 1.0, and the positive predictive value is 0.44 to 1.0, depending on the cutpoint. Among tuberculosis patients, the sensitivity is nearly the same as in the general population; the positive predictive value is 1.0. The area under the ROC curve is 0.997. The probability of M. tuberculosis infection at each induration size varies widely, depending on the prevalence. The optimal cutpoint varies from 2 mm to 16 mm and is dependent on prevalence and the purpose for testing.
CONCLUSIONS: The operating characteristics of the tuberculin test are superior to those of nearly all commonly used screening and diagnostic tests. The tuberculin test has an excellent ability to distinguish M. tuberculosis-infected from -uninfected persons. Interpretation requires consideration of prevalence and the purpose for testing. These findings support the recommendation to use different cutpoints for various populations. Even more accurate information can be gotten by interpreting induration size as indicating a probability of M. tuberculosis infection.

Entities:  

Mesh:

Year:  1995        PMID: 8583267     DOI: 10.1007/bf02602749

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  30 in total

1.  The booster phenomenon in serial tuberculin testing.

Authors:  N J Thompson; J L Glassroth; D E Snider; L S Farer
Journal:  Am Rev Respir Dis       Date:  1979-04

2.  Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity.

Authors:  C E PALMER; L B EDWARDS; L HOPWOOD; P Q EDWARDS
Journal:  J Pediatr       Date:  1959-10       Impact factor: 4.406

Review 3.  Immune mechanisms in the pathogenesis of pulmonary tuberculosis.

Authors:  A M Dannenberg
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

4.  Detection and quantification of carotid artery stenosis: efficacy of various Doppler velocity parameters.

Authors:  M G Hunink; J F Polak; M M Barlan; D H O'Leary
Journal:  AJR Am J Roentgenol       Date:  1993-03       Impact factor: 3.959

Review 5.  The tuberculin skin test.

Authors:  R E Huebner; M F Schein; J B Bass
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

6.  The tuberculin skin test.

Authors:  D E Snider
Journal:  Am Rev Respir Dis       Date:  1982-03

7.  Diagnostic and prognostic significance of the quantitative tuberculin tests. The influence of subclinical infections with atypical mycobacteria.

Authors:  D T Smith
Journal:  Ann Intern Med       Date:  1967-11       Impact factor: 25.391

8.  Sociologic concomitants of tuberculin sensitivity.

Authors:  J M Kuemmerer; G W Comstock
Journal:  Am Rev Respir Dis       Date:  1967-11

Review 9.  Laboratory diagnosis of iron-deficiency anemia: an overview.

Authors:  G H Guyatt; A D Oxman; M Ali; A Willan; W McIlroy; C Patterson
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

10.  The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group.

Authors:  A I Mushlin; A S Detsky; C E Phelps; P W O'Connor; D K Kido; W Kucharczyk; D W Giang; C Mooney; C M Tansey; W J Hall
Journal:  JAMA       Date:  1993 Jun 23-30       Impact factor: 56.272

View more
  21 in total

1.  Public health impact of targeted tuberculosis screening in public schools.

Authors:  Soju Chang; Lani S M Wheeler; Katherine P Farrell
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

2.  Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.

Authors:  Siang Tean Chin; Joshua Ignatius; Siti Suraiya; Gee Jun Tye; Maria E Sarmiento; Armando Acosta; Mohd Nor Norazmi; Theam Soon Lim
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

3.  Utility of functional status for classifying community versus institutional discharges after inpatient rehabilitation for stroke.

Authors:  Timothy A Reistetter; James E Graham; Anne Deutsch; Carl V Granger; Samuel Markello; Kenneth J Ottenbacher
Journal:  Arch Phys Med Rehabil       Date:  2010-03       Impact factor: 3.966

4.  Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.

Authors:  James D Mancuso; David Tribble; Gerald H Mazurek; Yuanzhang Li; Cara Olsen; Naomi E Aronson; Lawrence Geiter; Donald Goodwin; Lisa W Keep
Journal:  Clin Infect Dis       Date:  2011-08-01       Impact factor: 9.079

Review 5.  Close contact investigation of TB in high-burden, low- and middle-income countries.

Authors:  Y K Pang
Journal:  Malays Fam Physician       Date:  2014-08-31

6.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

Authors:  Benjamin L Laskin; Jens Goebel; Jeffrey R Starke; Daniel P Schauer; Mark H Eckman
Journal:  Am J Kidney Dis       Date:  2012-07-10       Impact factor: 8.860

8.  Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting.

Authors:  Jonathan L Zelner; Megan B Murray; Mercedes C Becerra; Jerome Galea; Leonid Lecca; Roger Calderon; Rosa Yataco; Carmen Contreras; Zibiao Zhang; Bryan T Grenfell; Ted Cohen
Journal:  Am J Epidemiol       Date:  2014-09-04       Impact factor: 4.897

9.  Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis.

Authors:  Aurelie Cobat; Caroline J Gallant; Leah Simkin; Gillian F Black; Kim Stanley; Jane Hughes; T Mark Doherty; Willem A Hanekom; Brian Eley; Jean-Philippe Jaïs; Anne Boland-Auge; Paul van Helden; Jean-Laurent Casanova; Laurent Abel; Eileen G Hoal; Erwin Schurr; Alexandre Alcaïs
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

Review 10.  Vaccines against tuberculosis: where are we and where do we need to go?

Authors:  Tom H M Ottenhoff; Stefan H E Kaufmann
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.